News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Mylan Inc. (MYL) Also Interested in Actavis, as Watson Pharmaceuticals, Inc. (WPI) Moves Closer to Deal: Report


3/29/2012 8:19:46 AM

Watson Pharmaceuticals Inc. (WPI) is nearing an agreement to purchase Swiss drugmaker Actavis Group hf, creating one of the world’s largest producers of generic drugs, according to people familiar with the process. Watson, based in Parsippany, New Jersey, may pay about 4.5 billion euros ($6 billion) for Actavis, two of the people said, declining to be identified because the talks are private. While a deal may be announced as soon as next week, it is more likely to come after Easter, the people said.

Read at News Release
Read at Bloomberg


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES